UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$745M |
| 2 |
Spotify
SPOT
|
+$727M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$689M |
| 4 |
Meta Platforms (Facebook)
META
|
+$680M |
| 5 |
NXP Semiconductors
NXPI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$1.33B |
| 2 |
Union Pacific
UNP
|
+$1.2B |
| 3 |
Equinix
EQIX
|
+$929M |
| 4 |
Broadcom
AVGO
|
+$805M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$685M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.43% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 10.41% |
| 5 | Communication Services | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Novartis
NVS
$297B
| $3.05M | ﹤0.01% |
+22,156
| New | +$2.9M |
|
1702
Sylvamo
SLVM
$1.5B
| $3.05M | ﹤0.01% |
63,365
+5,816
| +10% | +$265K |
|
|
NGD
1703
DELISTED
New Gold Inc
NGD
| $3.04M | ﹤0.01% |
+349,566
| New | +$2.63M |
|
|
CON
1704
Concentra Group Holdings
CON
$4.08B
| $3.04M | ﹤0.01% |
154,571
-65,754
| -30% | -$1.32M |
|
1705
Northwest Bancshares
NWBI
$2.25B
| $3.03M | ﹤0.01% |
252,659
+3,575
| +1% | +$43.5K |
|
1706
Alkami Technology
ALKT
$1.9B
| $3.02M | ﹤0.01% |
131,059
-4,750
| -3% | -$105K |
|
|
SEI
1707
Solaris Energy Infrastructure
SEI
$3.22B
| $3M | ﹤0.01% |
65,357
+21,859
| +50% | +$1.06M |
|
1708
Kinetik
KNTK
$3.59B
| $2.99M | ﹤0.01% |
83,014
-3,250
| -4% | -$117K |
|
1709
Syndax Pharmaceuticals
SNDX
$1.82B
| $2.99M | ﹤0.01% |
142,407
+8,146
| +6% | +$142K |
|
1710
Winnebago Industries
WGO
$879M
| $2.99M | ﹤0.01% |
73,833
+4,600
| +7% | +$168K |
|
1711
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
| $2.99M | ﹤0.01% |
+70,052
| New | +$3.1M |
|
1712
Alpha Metallurgical Resources
AMR
$1.85B
| $2.97M | ﹤0.01% |
14,876
-584
| -4% | -$101K |
|
1713
Appian
APPN
$1.88B
| $2.97M | ﹤0.01% |
83,915
+14,820
| +21% | +$528K |
|
1714
CoreCivic
CXW
$3.09B
| $2.97M | ﹤0.01% |
155,528
-5,778
| -4% | -$106K |
|
1715
First Advantage
FA
$3.43B
| $2.97M | ﹤0.01% |
204,159
-5,549
| -3% | -$78.2K |
|
1716
BioCryst Pharmaceuticals
BCRX
$2.43B
| $2.96M | ﹤0.01% |
378,853
-15,887
| -4% | -$115K |
|
1717
Central Garden & Pet Co Class A
CENTA
$2.39B
| $2.94M | ﹤0.01% |
100,610
+13,071
| +15% | +$378K |
|
1718
NovoCure
NVCR
$1.97B
| $2.93M | ﹤0.01% |
226,500
-969,124
| -81% | -$12.4M |
|
1719
Ivanhoe Electric
IE
$1.47B
| $2.93M | ﹤0.01% |
183,253
-18,655
| -9% | -$267K |
|
1720
Schwab International Equity ETF
SCHF
$65.9B
| $2.92M | ﹤0.01% |
+121,548
| New | +$2.89M |
|
1721
Buckle
BKE
$2.25B
| $2.92M | ﹤0.01% |
54,632
-706
| -1% | -$39.4K |
|
1722
Agios Pharmaceuticals
AGIO
$2.2B
| $2.91M | ﹤0.01% |
106,996
+121
| +0.1% | +$4.25K |
|
1723
CONMED
CNMD
$1.31B
| $2.91M | ﹤0.01% |
71,691
+3,746
| +6% | +$163K |
|
1724
REX American Resources
REX
$1.44B
| $2.91M | ﹤0.01% |
89,971
-1,999
| -2% | -$65.1K |
|
1725
Energizer
ENR
$1.44B
| $2.9M | ﹤0.01% |
145,941
+2,024
| +1% | +$44.1K |
|
Similar funds
UBS AM's Q4 2025 Portfolio in Review
As of Q4 2025, UBS AM held 3,345 positions worth $473B, up 2.7% from $461B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS AM's Q4 2025 filing shows 1,074 new, 1,062 increased, 1,120 reduced and 60 closed positions. Its largest new stake was Chubb: 2,548,307 shares worth $795M. The largest sale was Prologis, an estimated $1.33B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q4 2025 buy was Chubb: 2,548,307 shares worth $795M.
- UBS AM added most to Spotify in Q4 2025, an estimated $727M increase.
- UBS AM's biggest Q4 2025 reduction was Prologis, cutting an estimated $1.33B.
- UBS AM fully exited Kellanova in Q4 2025, selling an estimated $211M.
- UBS AM's ten largest holdings make up 36% of its $473B portfolio in Q4 2025.
- UBS AM opened 1,074 new positions and closed 60 in Q4 2025.
- UBS AM's portfolio value rose 2.7% quarter-over-quarter to $473B.
Based on UBS AM's 13F filing for Q4 2025, filed 13 Feb 2026.